Dr. Amaria on Genetically Modified TILs in Melanoma
1 Pogledi
• 07/03/23
0
0
Ugraditi
administrator
Pretplatnici
Rodabe N. Amaria, MD, Department of Melanoma Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses genetically modified tumor infiltrating lymphocytes (TILs) for patients with advanced melanoma.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari